查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2006519

製藥生產設備市場：按設備類型、技術、最終用戶和應用分類－2026-2032年全球市場預測

Pharmaceutical Manufacturing Equipment Market by Equipment Type, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，製藥生產設備市場價值將達到 205.5 億美元，到 2026 年將成長至 219.7 億美元，到 2032 年將達到 335.6 億美元，複合年成長率為 7.26%。

主要市場統計數據
基準年 2025 205.5億美元
預計年份：2026年 219.7億美元
預測年份 2032 335.6億美元
複合年成長率 (%) 7.26%

製藥生產設施是藥物研發和生產的核心，能夠將複雜的製劑轉化為安全有效的治療藥物。隨著行業面臨不斷變化的監管要求、日益成長的生物製藥需求以及最佳化成本和縮短上市時間的迫切需要，設施的選擇和整合已成為至關重要的戰略挑戰。各生產設施正在投資高精度壓片壓平機、先進的層析法設備和先進的生物反應器，以支援無菌生產流程。這些投資不僅能夠提高製程控制和產品品質，還能增強營運柔軟性，進而滿足個人化醫療和小批量生產的需求。

近年來，細胞療法和基因療法等新型治療方法的出現，進一步提升了專用發酵槽、一次性混合器和冷凍乾燥機等設備的重要性，這些設備能夠快速規模化生產。同時，傳統的固態製劑系統也不斷發展，自動化製粒機和流化床乾燥機的引入，使得顆粒尺寸分佈更加精確，包衣更加均勻。因此，生命科學公司優先考慮整合數位化監控、預測性維護和模組化架構的設備解決方案。這種綜合方法使生產線能夠在保持嚴格合規性的同時，快速切換不同的產品系列。

展望未來，至關重要的是要了解這些技術進步如何與不斷變化的市場動態和監管環境相互作用。以下章節將檢驗正在重塑醫療器材領域的變革性變化，並為評估這些新趨勢的策略意義奠定基礎。

因應顛覆性的技術和監管變革：重新定義製藥設施的效率和擴充性。

在自動化、數位化和監管要求的推動下，製藥器材產業正經歷著一場翻天覆地的變革。人工智慧驅動的自動化平台簡化了從膠囊填充到片劑包衣等複雜的生產流程，並即時最佳化程式參數。同時，資料驅動的品質源自於設計 (QbD) 框架正在取代傳統的批次放行通訊協定，從而實現主動控制策略，最大限度地減少偏差，確保產品特性的一致性。

評估美國2025年關稅對製藥設備供應鏈的多方面影響。

美國將於2025年實施的新關稅政策，為製藥生產設備的採購和部署帶來了顯著的複雜性。隨著進口機械和關鍵耗材關稅的提高，製造商面臨更高的資本投入和更長的交貨前置作業時間。這些成本壓力促使企業重新評估其供應商策略，並探索在免稅地區在地化生產流體化床乾燥機、發酵槽和層析法設備的方案。

透過按設備、技術、最終用戶和應用進行詳細的細分分析，揭示了關鍵的市場動態。

精準的市場區隔對於制定製藥設備產業的策略重點至關重要。在考慮設備類型時，必須將無菌加工設備、泡殼包裝機、膠囊填充機、層析法設備、發酵槽和生物反應器、流體化床乾燥機、製粒機、液體填充機、冷凍乾燥機、混合機和片劑加工系統納入考量，其中片劑包衣機和壓壓平機是重要的子類別。在技​​術細分方面，可重複使用設備因其耐用性和成本攤銷而備受青睞，而一次性設備則因其柔軟性和減少清潔驗證工作量而更具優勢。

區域市場分析：揭示美洲、歐洲、中東和非洲以及亞太地區的成長要素和戰略機會

區域趨勢在塑造製藥生產設備產業的未來發揮決定性作用。在美洲，強大的生物製藥開發平臺和政府對國內生產的獎勵，刺激了對一次性生物反應器、層析法系統和冷凍乾燥平台的強勁需求。北美的主要生產基地正在利用先進的分析技術和自動化手段對現有設施進行現代化改造，從而延長設備使用壽命並降低營運成本。

確定影響產業競爭力的關鍵製藥生產設備供應商及其策略措施。

領先的設備供應商透過結合內部創新、策略夥伴關係和有針對性的收購來脫穎而出。一些全球性公司正在透過收購無菌連接器和過濾裝置的細分市場製造商來擴展其一次性產品組合，從而為終端用戶提供更全面的即插即用解決方案。另一些公司則在投資數位雙胞胎和雲端監控平台，使製程工程師能夠在無需進行實際測試的情況下模擬放大場景並排查設備效能問題。

為行業領導者提供提升營運敏捷性和推動永續成長的實用策略和最佳實踐

行業領導者應優先考慮柔軟性和數位化整合，以保持競爭力。投資模組化、一次性系統有助於縮短驗證週期，並實現產品線之間的快速切換，從而促進向個人化治療的過渡。將硬體升級與先進的製程控制軟體結合，可即時掌握關鍵參數，使團隊能夠主動預防偏差，並保持穩定的產品品質。

一項全面的研究途徑，詳細說明了支撐研究可靠性的資料收集、檢驗和分析方法。

本研究採用嚴謹的研究架構，結合一手訪談、二手資料分析及量化檢驗方法。與製程工程師、品質保證經理和採購人員的專家討論，為了解設備性能、維護實務和策略性投資促進因素提供了第一手資料。除訪談外，透過廣泛查閱行業出版物、技術規範和監管指南，確保對市場趨勢的全面理解。

總結主要發現及其對全球製藥設備行業相關人員的戰略意義的結論。

本執行摘要闡述了先進製藥生產設備在支援穩健且高效的藥品生產中發揮的關鍵作用。透過探討從自動化和一次性技術到貿易政策影響等變革性趨勢，相關人員可以更準確地了解日益複雜的產業格局。細分市場分析揭示了不同設備類型、技術偏好、終端用戶類別和應用領域的需求差異，並強調了針對每個行業制定客製化策略的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 製藥生產設備市場：依設備類型分類

  • 無菌加工設備
  • 泡殼包裝機
  • 膠囊填充裝置
  • 層析法裝置
  • 發酵槽和生物反應器
  • 流體化床乾燥器
  • 造粒機
  • 液體填充機
  • 冷凍乾燥機
  • 混合器
  • 片劑生產設備
    • 片劑包衣機
    • 壓平機片機

第9章 製藥生產設備市場：依技術分類

  • 可重複使用設備
  • 免洗設備

第10章 製藥生產設備市場：依最終用戶分類

  • 契約製造組織
  • 製藥公司
  • 研究和學術機構
  • 研究機構

第11章 製藥生產設備市場：依應用領域分類

  • 無菌灌裝
  • 生物製藥生產
  • 口服液體製劑的生產
  • 注射劑的生產
  • 固態劑型的生產

第12章 製藥生產設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 製藥生產設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 製藥生產設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國製藥生產設備市場

第16章：中國製藥設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ACG Pvt. Ltd.
  • ACIC Pharmaceuticals Inc.
  • Alfa Laval AB
  • Ambica Pharma Machines Pvt. Ltd.
  • GEA Group Aktiengesellschaft
  • Glatt GmbH
  • IDEX Corporation
  • IMA Group
  • Jinhu Ginhong Machinery Co., Ltd.
  • Komachine Inc.
  • Korber AG
  • Lee Industries
  • Maquinaria Industrial Dara, SL
  • Marchesini Group SpA
  • MG2 srl
  • Niverplast BV
  • Paul Mueller Company
  • Romaco Group
  • Shinva Medical Instrument Co., Ltd.
  • Solvay SA
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.
  • UNITED PHARMATEK LLC
Product Code: MRR-961BA04A2E92

The Pharmaceutical Manufacturing Equipment Market was valued at USD 20.55 billion in 2025 and is projected to grow to USD 21.97 billion in 2026, with a CAGR of 7.26%, reaching USD 33.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.55 billion
Estimated Year [2026] USD 21.97 billion
Forecast Year [2032] USD 33.56 billion
CAGR (%) 7.26%

Pharmaceutical manufacturing equipment sits at the heart of drug development and production, enabling the translation of complex formulations into safe, effective therapies. As the industry contends with evolving regulatory requirements, rising demand for biologics, and the imperative to optimize cost and time to market, equipment selection and integration have become critical strategic considerations. Facilities are investing in high-precision tablet presses, state-of-the-art chromatography suites, and advanced bioreactors that support aseptic processing. These investments not only enhance process control and product quality but also foster the operational flexibility needed to address personalized medicine and small-batch production.

In recent years, the entry of novel therapeutic modalities such as cell and gene therapies has further elevated the role of specialized fermenters, single-use mixers, and lyophilizers in enabling rapid scale-up. Meanwhile, traditional solid dosage systems have continued to evolve, featuring automated granulators and fluid bed dryers that deliver tighter particle size distribution and uniform coating. Consequently, life science companies are prioritizing equipment solutions that integrate digital monitoring, predictive maintenance, and modular architectures. This holistic approach ensures that manufacturing lines can pivot swiftly between diverse product portfolios while maintaining rigorous compliance.

Looking ahead, understanding how these technological advancements intersect with shifting market dynamics and regulatory environments will be essential. The following section examines the transformative shifts reshaping the pharmaceutical equipment landscape and sets the stage for assessing the strategic implications of emerging trends.

Navigating Disruptive Technological and Regulatory Transformations Redefining Pharmaceutical Equipment Efficiency and Scalability

The pharmaceutical equipment landscape is undergoing seismic transformation as advances in automation, digitalization, and regulatory expectations converge. Automation platforms embedded with artificial intelligence are streamlining complex workflows, from capsule filling to tablet coating, by optimizing process parameters in real time. Concurrently, data-driven quality by design frameworks are replacing traditional batch release protocols, enabling proactive control strategies that minimize deviations and ensure consistent product attributes.

Single-use technologies have moved beyond niche applications to become mainstream, particularly in biopharmaceutical manufacturing environments where contamination risks and cleaning validation costs drive demand for disposable systems. This shift has challenged equipment manufacturers to expand their portfolios to include sterile connectors, prevalidated assemblies, and modular fluid handling units. In parallel, continuous processing architectures are gaining traction for both small molecule and biologic production, promising reduced footprint, lower energy consumption, and improved yield stability.

Regulatory agencies across key markets are also reshaping the landscape. Recent guidance has emphasized process analytical technologies, real-time release testing, and lifecycle management practices, compelling equipment suppliers and end users to collaborate early in development. Supply chain resilience has emerged as another critical axis of transformation, with firms diversifying component sourcing and exploring nearshoring strategies to mitigate geopolitical uncertainties. Taken together, these disruptive forces are redefining efficiency, scalability, and risk management in pharmaceutical manufacturing.

Assessing the Multifaceted Consequences of United States Tariffs on Pharmaceutical Manufacturing Equipment Supply Chains in 2025

The implementation of new United States tariffs in 2025 has introduced significant complexity to the procurement and deployment of pharmaceutical manufacturing equipment. As duties increase on imported machinery and critical consumables, manufacturers have encountered rising capital expenditure requirements and extended lead times. These cost pressures have prompted organizations to reassess supplier strategies, exploring options to localize production of fluid bed dryers, fermenters, and chromatography units in tariff-free jurisdictions.

The ramifications extend beyond direct cost increases. Equipment vendors facing higher import duties are recalibrating pricing models and, in some cases, shifting inventory buffers to domestic warehouses. End users have responded by grouping orders into larger shipments to dilute tariff impacts or renegotiating long-term service contracts to secure fixed pricing. Meanwhile, the threat of further trade restrictions has accelerated interest in distributed manufacturing networks, where modular tablet processing and liquid filling systems can be deployed closer to end markets.

Despite these challenges, strategic adaptation has unlocked opportunities for equipment innovators. Firms that have invested in local engineering capabilities and decentralized assembly facilities are better positioned to maintain delivery timelines and preserve margins. Moreover, the tariffs have intensified collaboration between manufacturers and financial services providers, leading to creative leasing structures and equipment-as-a-service offerings that defer upfront capital outlay. Ultimately, navigating the 2025 tariff environment will demand agility, foresight, and the willingness to embrace alternative procurement models.

Uncovering Critical Market Dynamics through Detailed Equipment, Technology, End User, and Application Segmentation Insights

A nuanced understanding of market segmentation is essential to charting strategic priorities within the pharmaceutical equipment sector. When examining equipment types, one must consider aseptic processing equipment, blister packaging machines, capsule filling equipment, chromatography instruments, fermenters and bioreactors, fluid bed dryers, granulators, liquid filling machines, lyophilizers, mixers, and tablet processing systems, with tablet coating machines and tablet presses forming critical subcategories. Technology segmentation further distinguishes between reusable equipment-valued for its longevity and cost amortization-and single use equipment, which provides flexibility and reduced cleaning validation burdens.

End users span contract manufacturing organizations that deliver turnkey production services, pharmaceutical companies driving in-house manufacturing, research and academic institutes fostering early-stage innovation, and specialized research institutes focusing on advanced therapeutics. Application segmentation highlights the breadth of use cases, extending from aseptic filling operations to biopharmaceutical manufacturing, oral liquid production, parenteral processing, and solid dosage form creation. This layered segmentation framework reveals that demand drivers vary significantly by category: bioreactor and single-use mixer uptake is strongest in the biopharma segment, whereas granulators and tablet presses remain mainstays for solid dose players.

By aligning product development roadmaps with these segment dynamics, equipment providers can prioritize feature sets and geographic roll-out strategies that resonate most powerfully within each niche. Moreover, end users can tailor capital investments and maintenance programs according to the risk profile and regulatory intensity associated with their core applications.

Regional Market Intelligence Illuminating Growth Drivers and Strategic Opportunities across the Americas, EMEA, and Asia-Pacific Landscapes

Regional dynamics play a defining role in shaping the pharmaceutical manufacturing equipment sector's trajectory. In the Americas, strong biopharmaceutical R&D pipelines and government incentives for domestic production have stimulated robust demand for single use bioreactors, chromatography systems, and lyophilization platforms. Key hubs in North America are also leveraging advanced analytics and automation to modernize legacy facilities, thereby extending equipment lifecycles and reducing operational expenditures.

The Europe, Middle East & Africa region exhibits a more diverse set of drivers. Western European markets continue to lead in continuous processing adoption and integration of industry 4.0 solutions, supported by stringent regulatory regimes that emphasize quality by design. In contrast, emerging markets across the Middle East and Africa are investing in blister packaging and liquid filling lines to meet growing generic drug demand, with local regulatory bodies gradually strengthening manufacturing standards to align with global best practices.

Asia-Pacific stands out for its rapid capacity additions and cost-competitive manufacturing base. Countries such as India and China are scaling up granulators, tablet presses, and fluid bed dryers to serve both domestic and export markets. Simultaneously, regional governments are offering incentives for advanced bioreactor installations and funding collaborative centers of excellence. Connectivity initiatives are also fostering cross-border partnerships that accelerate technology transfer and localize after-sales support.

Identifying Leading Pharmaceutical Manufacturing Equipment Providers and Their Strategic Initiatives Shaping Industry Competitiveness

Leading equipment providers are differentiating themselves through a mix of organic innovation, strategic partnerships, and targeted acquisitions. Several global firms have expanded their single-use portfolio by acquiring niche manufacturers of sterile connectors and filtration units, thereby offering end users more comprehensive plug-and-play solutions. Others have invested in digital twins and cloud-enabled monitoring platforms, allowing process engineers to simulate scale-up scenarios and troubleshoot equipment performance without physical trials.

Collaborations between technology specialists and research institutions are also on the rise, resulting in co-developed chromatography resins and advanced sensor arrays that deliver tighter process control. Meanwhile, certain legacy suppliers have focused on modular skid-based systems, enabling contract manufacturers to rapidly configure production lines for new molecule launches. Service differentiation has become equally important, with firms offering predictive maintenance contracts and embedded remote diagnostics that proactively address equipment health issues.

Competition is further intensified by emerging players from adjacent industries, such as semiconductor equipment vendors entering the bioprocessing space with precision fluidics and contamination control expertise. This dynamic landscape underscores the importance of agility, with top performers continually refining their go-to-market strategies and leveraging cross-segment insights to anticipate customer needs.

Actionable Strategies and Best Practices for Industry Leaders to Enhance Operational Agility and Drive Sustainable Growth

Industry leaders should prioritize flexibility and digital integration to remain competitive. Investing in modular, single-use systems can reduce validation cycles and enable rapid changeover between product lines, supporting a shift toward personalized therapies. Complementing hardware upgrades with advanced process control software will provide real-time visibility into critical parameters, allowing teams to preempt deviations and maintain consistent output quality.

Diversifying supply chains is equally essential in the current geopolitical climate. Establishing partnerships with regional equipment assemblers and adopting equipment-as-a-service models can mitigate exposure to tariffs and logistical disruptions. Additionally, engaging early with regulatory authorities to align on process analytical technology roadmaps can streamline approvals and reduce post-approval modifications.

Finally, fostering cross-functional collaboration between R&D, engineering, and operations teams will accelerate technology adoption and drive continuous improvement. By embedding a culture of innovation, organizations can harness data insights to refine workflows, optimize utility consumption, and scale capacity efficiently. This holistic approach balances cost discipline with agility, positioning firms to capitalize on emerging therapeutic trends and evolving market demands.

Comprehensive Research Approach Detailing Data Collection, Validation, and Analytical Methods Underpinning Study Credibility

This study was developed through a rigorous research framework combining primary interviews, secondary data analysis, and quantitative validation techniques. Expert discussions with process engineers, quality assurance managers, and procurement directors provided firsthand insights into equipment performance, maintenance practices, and strategic investment drivers. Supplementing these interviews, an extensive review of industry publications, technical specifications, and regulatory guidelines ensured a comprehensive understanding of market trends.

Data triangulation methods were applied to corroborate findings across multiple sources. Equipment shipment records, patent filings, and academic research outputs were cross-referenced to confirm technology adoption timelines. Furthermore, a structured scoring model evaluated vendor capabilities against criteria such as innovation pipeline strength, service network coverage, and digital platform maturity. This model enabled objective comparisons and highlighted areas of competitive differentiation.

Throughout the process, quality controls were maintained via iterative peer reviews and validation checkpoints. Analysts continuously refined assumptions, updated contextual factors, and solicited feedback from advisory board members with deep domain expertise. The result is a robust and transparent methodology that underpins the study's strategic recommendations and ensures actionable intelligence for decision makers.

Conclusive Insights Summarizing Key Findings and Strategic Implications for Global Pharmaceutical Equipment Stakeholders

This executive summary has highlighted the critical role of advanced pharmaceutical manufacturing equipment in supporting robust and efficient drug production. By exploring transformative trends-from automation and single-use technologies to trade policy impacts-industry stakeholders can better navigate an increasingly complex landscape. Segmentation analysis has illuminated distinct demand profiles across equipment types, technology preferences, end-user categories, and application areas, underscoring the need for tailored strategies.

Regional insights reveal that the Americas, EMEA, and Asia-Pacific each present unique growth drivers and challenges, whether it be biopharma innovation clusters, regulatory harmonization efforts, or cost-competitive capacity expansions. Competitive intelligence underscores the importance of strategic partnerships, digital service offerings, and modular system architectures in differentiating vendor propositions. Finally, actionable recommendations emphasize flexibility, supply chain diversification, and data-driven process control as key enablers of sustainable growth.

Armed with these findings, equipment providers and end users alike can make informed decisions that balance operational efficiency with technological agility. Embracing a holistic approach to equipment strategy will be essential to unlocking new opportunities, managing risk, and achieving long-term success in the evolving pharmaceutical manufacturing ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Manufacturing Equipment Market, by Equipment Type

  • 8.1. Aseptic Processing Equipment
  • 8.2. Blister Packaging Machines
  • 8.3. Capsule Filling Equipment
  • 8.4. Chromatography Equipment
  • 8.5. Fermenters & Bioreactors
  • 8.6. Fluid Bed Dryers
  • 8.7. Granulators
  • 8.8. Liquid Filling Machines
  • 8.9. Lyophilizers
  • 8.10. Mixers
  • 8.11. Tablet Processing Equipment
    • 8.11.1. Tablet Coating Machine
    • 8.11.2. Tablet Press

9. Pharmaceutical Manufacturing Equipment Market, by Technology

  • 9.1. Reusable Equipment
  • 9.2. Single Use Equipment

10. Pharmaceutical Manufacturing Equipment Market, by End User

  • 10.1. Contract Manufacturing Organizations
  • 10.2. Pharmaceutical Companies
  • 10.3. Research & Academic Institutes
  • 10.4. Research Institutes

11. Pharmaceutical Manufacturing Equipment Market, by Application

  • 11.1. Aseptic Filling
  • 11.2. Biopharmaceutical Manufacturing
  • 11.3. Oral Liquid Manufacturing
  • 11.4. Parenteral Manufacturing
  • 11.5. Solid Dosage Manufacturing

12. Pharmaceutical Manufacturing Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Pharmaceutical Manufacturing Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Pharmaceutical Manufacturing Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Pharmaceutical Manufacturing Equipment Market

16. China Pharmaceutical Manufacturing Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ACG Pvt. Ltd.
  • 17.6. ACIC Pharmaceuticals Inc.
  • 17.7. Alfa Laval AB
  • 17.8. Ambica Pharma Machines Pvt. Ltd.
  • 17.9. GEA Group Aktiengesellschaft
  • 17.10. Glatt GmbH
  • 17.11. IDEX Corporation
  • 17.12. IMA Group
  • 17.13. Jinhu Ginhong Machinery Co., Ltd.
  • 17.14. Komachine Inc.
  • 17.15. Korber AG
  • 17.16. Lee Industries
  • 17.17. Maquinaria Industrial Dara, S.L.
  • 17.18. Marchesini Group S.p.A.
  • 17.19. MG2 s.r.l.
  • 17.20. Niverplast B.V.
  • 17.21. Paul Mueller Company
  • 17.22. Romaco Group
  • 17.23. Shinva Medical Instrument Co., Ltd.
  • 17.24. Solvay S.A.
  • 17.25. Syntegon Technology GmbH
  • 17.26. Thermo Fisher Scientific Inc.
  • 17.27. UNITED PHARMATEK LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 162. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)